Skip to main content

Movers & Shakers: Oct 7, 2011


Gail Page has stepped down as chairman of the board at Vermillion. Page will still remain CEO. In her place, the company elected James Burns as chairman.

Burns has been a director of the board since 2005, and is the president and CEO of AssureRx. Previously he was president and CEO of EntreMed.

Waters has recognized the University of Minnesota's Mass Spectrometry Laboratory as a Waters Center of Innovation, citing in particular the work of the facility's head Joseph Dalluge.

Dalluge is the thirteenth researcher recognized by the program. His research focuses on diagnostic marker development for cystic fibrosis and other diseases, using LC-MS instruments including Waters' Aqcuity UPLC/TQD and Synapt G2 for metabolite profiling, biomarker discovery, and chemical characterization of biological systems.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.